MicroMaxx Successfully Launched/Shipments Begun on Schedule Sr. VP Marketing and VP Enterprise Sales Appointments Announced Conference call at 1:30 PT/4:30ET Today… [Read more]
Company begins on schedule delivery of third generation product to hospitals and physicians worldwide following successful second quarter launch… [Read more]
BOTHELL, WA - April 13, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that it will present at the WBBA (Washington Biotechnology and Biomedical Association) Invest Northwest„¢ 2005 Conference at the Bell Harbor Conference Center in Seattle on Wednesday, April 27 at 08:30 a.m. (PT). The presentation will include a review of the company's business strategy and historical financial results. A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days.
About Sonosite… [Read more]
US Sector Achieves an All Time High in Quarterly Revenues of $40 Million, Up 35%
VisualSonics (VSI) Acquisition Delivers Second Consecutive Strong Quarter
Company Experienced Improving Momentum and Market Dynamics
BOTHELL, WA – January 10, 2011 – Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced preliminary revenue results for the fourth quarter and year ended December 31, 2010.
Revenue for the fourth quarter was approximately $89 million, an increase of 27% for the quarter. Full-year 2010 revenue reached $275 million compared to $227 million in 2009, an increase of 21%.
VisualSonics revenue was $8.8 million for the quarter, representing the second consecutive strong performance since the company was acquired in June 2010.
Sonosite revenue, excluding VSI, was approximately $80 million, an increase of 15% compared to the fourth quarter of 2009, and $257 million for the full-year, an increase of 13%.… [Read more]
BOTHELL, WA – December 20, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, Sonosite’s President and CEO, will present at the 29th Annual JP Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 10-13, 2011.
The session will be webcast live on Wednesday, January 12, 2011 at 9:30 am Pacific Time. An audio replay will be available for 30 days following and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. … [Read more]
Live Presentation Available Via Audio-WebcastBOTHELL, WA, October 3, 2002 - Sonosite, Inc. (Nasdaq: SONO), the creator and leader of hand-carried diagnostic ultrasound, today announced that Kevin M. Goodwin, president and CEO of Sonosite, will present at the UBS Warburg Global Life Sciences Conference at 2:30 p.m. (EDT) on Tuesday, October 8, 2002, at the Plaza Hotel in New York City. Interested investors can hear a live audio-webcast at http://www.ubswarburg.com. The audiocast will be archived on the site until November 10, 2002.About SonositeSonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.… [Read more]
Worldwide Revenues Increase 55 Percent, Gross Margins Rise for Seventh Consecutive Quarter to 59.5 PercentBOTHELL, WA, October 23, 2002 - Sonosite, Inc. (Nasdaq: SONO), the leader and creator of hand-carried ultrasound, today released financial results for the third quarter ended September 30, 2002. For the quarter, Sonosite reported revenues of $18.5 million vs. $11.9 million for the third quarter of 2001, an increase of 55 percent. For the nine months, revenues were $47.9 million, an increase of 58 percent, compared to $30.4 million in the first nine months of 2001.Sonosite reported a net loss of $2.4 million, or $0.17 per share, for the quarter compared to a net loss of $2.3 million, or $0.21 per share, for the comparable quarter in the prior year. Gross margins increased for the seventh consecutive quarter to 59.5 percent, compared to 56.6 percent in the third quarter of 2001. For the nine months, the net loss totaled $8.6 million, or $0.68 per share, vs. $14.0 million, or $1.41 per share, for the period a year earlier. As of September 30, 2002, cash, cash equivalents and investment securities totaled $69.3 million.Worldwide, Sonosite's revenues increased in each of its major geographic markets. Compared to the same quarter in 2001, revenues rose 75 percent in the U.S., 64 percent in Europe and 10 percent in the JPLAC region (Japan, Asia, Latin America, Australia and Canada).… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA, September 30, 2002 - Sonosite, Inc. (Nasdaq: SONO), today announced that the Company will report its third quarter earnings results on Wednesday, October 23, 2002, after market close. Sonosite's management team will host a conference call on Wednesday, October 23 at 1:30 p.m. (PDT) to discuss the company's third quarter results. The call will be broadcast live via the "Investors" section of Sonosite's corporate website: http://ir.sonosite.com/.A replay of the call will be available by calling (719) 457-0820 or toll-free (888) 203-1112. Replay access will be available until 8 p.m. (PDT) on Thursday, October 24, 2002. The confirmation code 428460 is required for replay access. The call will be archived on Sonosite's website until November 23, 2002, at http://ir.sonosite.com/.About Sonosite… [Read more]
Sonosite Recognized For Its 346 Percent Revenue Growth Over The Past Three YearsBOTHELL, WA, September 27, 2002 - Sonosite, Inc. (Nasdaq: SONO) has been named a Rising Star and one of the fastest growing technology companies in Washington State by Deloitte & Touche. The Rising Star category is a part of the "Technology Fast 50" program and consists of companies in business less than five years, but more than three years, based on percentage of growth in revenues for three years (1999 to 2001)."To make the Deloitte & Touche Technology Fast 50 Rising Star list, a company must have had tremendous revenue growth from 1999-2001," said Larry Hile, Partner-in-charge of the Technology, Media and Telecommunications Practice for Deloitte & Touche's Northwest Practice. "We at Deloitte & Touche applaud Sonosite for having the long-term vision to develop technologies that change the way we work and care for one another."Sonosite's President and CEO, Kevin M. Goodwin, credits the company's innovative and expansive technology and strong worldwide sales force with the 346 percent revenue growth over the three-year time period through June 2002. Sonosite recognized its first commercial revenue in September 1999.… [Read more]
Conference Call Accessible Via Live Webcast
BOTHELL, WA, January 13, 2003 - Sonosite, Inc. (Nasdaq: SONO), today announced that the Company will report its fourth quarter and 2002 year-end earnings results on Thursday, February 13, 2003, after market close. Sonosite's management team will host a conference call on Thursday, February 13 at 1:30 p.m. (PST) to discuss the Company's fourth quarter and year-end results. The call will be broadcast live via the "Investors" section of Sonosite's corporate website: http://ir.sonosite.com/.… [Read more]
Acquisition of SonoMetric Health Signals Expansion into Preventive CardiologyUltrasound-based Software Helps Determine Cardiovascular RiskBOTHELL, WA, May 27, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, announced today that it has acquired privately held SonoMetric Health, Inc., a developer of proprietary software to assess and manage cardiovascular disease in conjunction with an ultrasound examination. Terms of the agreement with SonoMetric were not disclosed. The transaction is not expected to have a material impact on Sonosite's 2004 financial results. "This acquisition is the initial step in implementing our preventive cardiology strategy and expanding our focus on providing ultrasound tools for detecting and managing cardiovascular disease," said Kevin M. Goodwin, Sonosite President and CEO. "We believe that the software developed by SonoMetric, when paired with our current and future hand-carried technologies, offers a major opportunity to impact the early stages of cardiovascular disease when treatment is most effective and that this technology can be cost-effectively leveraged throughout the care path, including the patient's physical exam." … [Read more]
Live Presentation Available Via Audio-WebcastBOTHELL, WA, May 5, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that Kevin M. Goodwin, president and CEO of Sonosite, will present at the Deutsche Bank Health Care Conference at 3:00 pm. (EDT) on Wednesday May 5, 2004 at the Renaissance Harborplace Hotel in Baltimore.About SonositeSonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.… [Read more]
BOTHELL, WA, June 30, 2004 - Sonosite, Inc. (Nasdaq: SONO), the worldwide leader in high-performance, hand-carried ultrasound, announced today that it has signed a distribution agreement for Japan with Aloka Co., Ltd., a leading Japanese manufacturer and distributor of ultrasound systems. The agreement names Aloka as Sonosite's exclusive distributor for TITAN, the Company's newest generation of high performance, hand-carried ultrasound systems, for all of Japan's clinical ultrasound markets, including cardiology, abdominal, vascular, Ob/gyn and emergency medicine. "This agreement brings together two leaders in ultrasound," said Mr. Yoshihiro Yoshikawa, President, Aloka Co. Ltd. "Hand-carried ultrasound is Japan's most rapidly growing ultrasound market. Aloka is fully committed to optimizing this major opportunity through this strategic alliance with Sonosite and to bringing the finest hand-carried ultrasound available to Japan's medical practitioners." … [Read more]
SEATTLE, WA, July 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, and Nippon Sherwood Medical Industries Ltd., Japan's leading manufacturer of central venous catheters (CVCs), announced today that they have signed a two-year distribution agreement for the Japanese vascular access market. Under the terms of the agreement, Nippon Sherwood will become the exclusive distributor of Sonosite's iLook' 25 system for the vascular access market in Japan. Weighing only 3 pounds (1.4kg.), the all-digital iLook 25 system is specifically designed to provide fast, accurate guidance for vascular access. The alliance will leverage Nippon Sherwood's strong distribution channels to deliver the iLook25 system to catheterization labs, surgical suites, critical care units and other point-of-care locations where catheters and lines for vascular access are placed. "We are excited about the growing opportunity for the Sonosite iLook 25 product in Japan," said Seiji Kato, general manager of Sales and Marketing of Nippon Sherwood. "The use of ultrasound guidance for vascular line placement has been shown to improve patient safety and comfort associated with these interventional procedures and is becoming standard medical practice in the United States and United Kingdom. We look forward to working with Sonosite to pioneer this market in Japan and establishing the iLook 25 system as the new standard of care for CVC procedures in this country."… [Read more]
International Revenue increases 81%TITAN Sales Exceed 60% of Worldwide RevenueJapan Distribution Agreement Signed for iLook 25 … [Read more]
BOTHELL, WA - September 17, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York on Wednesday, September 29, 2004 at 10:30 a.m. (EDT). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About SonositeSonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.… [Read more]
BOTHELL, WA, August 2, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, today announced that, in accordance with Nasdaq Marketplace Rule 4350, a non-officer employee was granted inducement stock options for 15,000 shares of common stock on July 27, 2004. These options were granted pursuant to Nasdaq Marketplace Rule 4350 (i)(1)(A)(iv). Each option has been classified as a non-qualified stock option, has an exercise price equal to the fair market value on the grant date, has a ten-year term, and vests 25% on the one year anniversary of the option grant date with an additional 2.0833% vested each month thereafter, with 100% being vested and exercisable four years from the option grant date.About SonositeSonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.… [Read more]
Mediwatch to Distribute Sonosite Products to UK Urology MarketSonosite Technology to be Incorporated into Mediwatch's Prostate Assessment ProductLONDON, September 2, 2004 - Sonosite Inc. (Nasdaq: SONO), the worldwide leader in high performance, hand-carried ultrasound, announced today that Sonosite, Ltd., the Company's United Kingdom (UK) subsidiary, has entered into two distribution and supply agreements with Mediwatch Plc., (LSE:MDW.L) a leading developer, manufacturer and distributor of advanced urological primary care products for the screening, diagnosis and assessment of urological disease and disorders. Under the terms of the first agreement, Mediwatch will become an authorised distributor of Sonosite's hand-carried ultrasound systems for the UK urology market. Pursuant to the second agreement, Sonosite will supply Mediwatch with its TITAN ultrasound technology to be incorporated into Mediwatch's proprietary 'One Stop' Prostate Assessment System, which is currently under development and Mediwatch intends to market worldwide when completed. Mediwatch's 'One Stop' Prostate Assessment System is designed to provide the physician with a complete system for the diagnosis and assessment of prostate health in the clinic and will include imaging, urinalysis and blood testing capabilities. … [Read more]